HBS’ Pharmaceutical division focuses on a number of specific aspects of our clients’ strategic needs. Thus we do not undertake market study type projects which are serviced by other highly focused agencies.
Our projects address questions such as differentiation through corporate responsibility, brand value in the generics market, improved drug delivery mechanisms or market specific packaging.
These, and issues like these, are increasingly key in a market where differentiation is now less driven by block buster drugs but instead by the need for relationship building. These relationships are being formed in new constellations of stakeholders, having moved away from the traditional physician - drug company focus. This is compounded by the increased scrutiny pharmaceutical companies have come under concerning their marketing and sales efforts. Furthermore, especially in developing countries, these factors are often a prerequisite to enter or grow a market. HBS has special expertise in these types of projects, having formed excellent long term working relationships with intergovernmental and governmental agencies, NGOs and foundations.